This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chao NJ, Emerson SG, Weinberg KI . Stem cell transplantation (cord blood transplants). Hematol Am Soc Hematol Educ Program 2004, 354–371.
Georges G, Storb R . Failure of sustained engraftment: clinical manifestations and treatment. In: Atkinson K (eds). Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edn. Cambridge University Press: Cambridge, UK, 2000. pp 1088–1188.
Tomonari A, Iseki T, Ooi J, Takahashi S, Shindo M, Ishii K et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol 2003; 121: 304–311.
Yoshikawa T . Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 2004; 124: 421–432.
Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000; 111: 292–302.
Platzbecker U, Thiede C, Freiberg-Richter J, Helwig A, Mohr B, Prange G et al. Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF. Ann Hematol 2001; 80: 144–149.
Bolwell B, Sobecks R, Pohlman B, Andresen S, Rybicki L, Kuczkowski E et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 34: 621–625.
Denton M, Kerr KG . Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57–80.
Ohwada C, Nakaseko C, Ozawa S, Takeuchi M, Shono K, Koizumi M et al. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplant 2004; 34: 999–1000.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, Y., Tanaka, Y., Ando, T. et al. Successful engraftment of the second reduced-intensity conditioning cord blood transplantation (CBT) for a patient who developed graft rejection and infectious complications after the first CBT for AML. Bone Marrow Transplant 40, 395–396 (2007). https://doi.org/10.1038/sj.bmt.1705732
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705732
This article is cited by
-
Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections
International Journal of Hematology (2009)